Ursprung des Netzwerks ersten Grades von Lennart Gisselsson
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
LU Holding AB
LU Holding AB Investment ManagersFinance LU Holding AB (LU Holding) is a venture capital subsidiary of University of Lund founded in 1994. The firm is headquartered in Lund, Sweden.
2
| Subsidiary | Investment Managers | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Lennart Gisselsson
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
SAGA Diagnostics AB
SAGA Diagnostics AB Medical/Nursing ServicesHealth Services Saga Diagnostics AB operates as a personalized cancer medicine and disease monitoring company. The firm's services include Gene Mutation analysis, circulating tumor DNA and Chromosome analysis. The company was founded by Lao Saal and Anthony George in 2016 and is headquartered in Lund, Sweden. | Medical/Nursing Services | Chairman | |
Akuru Pharma AB
Akuru Pharma AB BiotechnologyHealth Technology Akuru Pharma AB engages in the development of research and technology. It focuses on exploiting the abnormal expression of transporter proteins in kidney cancer for developing novel diagnostic and treatment modalities. The company was founded by Jennifer Hansson, Hakan Axelson, and Johanna Asklin on April 14, 2016 and is headquareterd in Lund, Sweden. | Biotechnology | Director/Board Member | |
SARomics Biostructures AB
SARomics Biostructures AB BiotechnologyHealth Technology SARomics Biostructures AB provides protein three-dimensional structure determination and structure-based drug discovery services. The firm develops premium structural biology services. It offers crystallography services, which include crystallization screen and structure determination, nuclear magnetic resonance spectroscopy services, such as ligand binding assays/fragment screening, structure determination, and verification of the structural integrity of target protein, gene-to-structure services, such as protein cloning, expression, purification, and structure determination, kinase structures and kinobits, which include pre-made complexes of kinases with small-molecule fragments to serve as a starting point in a discovery project, structure-based drug discovery services, such as hit identification, hit optimization, and lead generation, gene-to lead services, including a combination of gene-to-structure and structure-based drug discovery, and structure-activity protein optimization services. The company was founded by Björn Ulrik Walse, Sven Anders Mikael Akke, Derek W. Logan, Salam Al-Karadaghi, and Bo Svensson in 2006 and is headquartered in Lund, Sweden. | Biotechnology | Director/Board Member | |
ARCEDE PHARMA AB | Miscellaneous Commercial Services | Director/Board Member | |
University of Gothenburg | College/University | Doctorate Degree |
Statistik
International
Schweden | 6 |
Sektoral
Health Technology | 3 |
Health Services | 2 |
Commercial Services | 2 |
Consumer Services | 2 |
Operativ
Director/Board Member | 3 |
Private Equity Analyst | 2 |
Chairman | 1 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Johanna Asklin | 6 |
Mattias Segerström | 1 |
- Börse
- Insiders
- Lennart Gisselsson
- Unternehmensverbindungen